Genetic Testing

Cizzle Bio Announces Laboratory Validation of CIZ1B Biomarker Blood Test for Early Lung Cancer at OmniHealth Diagnostics

DALLAS, June 16, 2026 /PRNewswire/ -- Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of…

3 months ago

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat…

3 months ago

Sharecare wins 14 Digital Health Awards in Spring 2026 competition

Company earns five Golds for its interactive patient education tools, health literacy content, and evidence-based behavioral health appsATLANTA, June 11,…

3 months ago

Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026

BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming…

4 months ago

Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates

The move brings Genetic Optimization to one of the most sought-after fertility clinics in the U.S., following Nucleus’ rapid global…

4 months ago

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired…

4 months ago

Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc.…

5 months ago

Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad…

5 months ago

GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite

AI-powered innovation transforms complex genetic data into clear, actionable insights for clinicians and individuals Genomics + AI for Longevity Transforming…

5 months ago

Laurent C.A. Melchior Tellier Returns to Original Role as CEO of Genomic Prediction

NEWARK, N.J., April 17, 2026 /PRNewswire/ -- Genomic Prediction, Inc., a leader in advanced genetic testing and reproductive genomics, announced…

5 months ago